CN107142272A - 一种控制大肠杆菌中质粒复制的方法 - Google Patents

一种控制大肠杆菌中质粒复制的方法 Download PDF

Info

Publication number
CN107142272A
CN107142272A CN201710413737.XA CN201710413737A CN107142272A CN 107142272 A CN107142272 A CN 107142272A CN 201710413737 A CN201710413737 A CN 201710413737A CN 107142272 A CN107142272 A CN 107142272A
Authority
CN
China
Prior art keywords
plasmid
regulation
grna
control
replication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710413737.XA
Other languages
English (en)
Inventor
黄小罗
方惠敏
张丽华
柳振宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Jinsirui Science and Technology Biology Corp
Original Assignee
Nanjing Jinsirui Science and Technology Biology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Jinsirui Science and Technology Biology Corp filed Critical Nanjing Jinsirui Science and Technology Biology Corp
Priority to CN201710413737.XA priority Critical patent/CN107142272A/zh
Publication of CN107142272A publication Critical patent/CN107142272A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00Vectors comprising a targeting moiety
    • C12N2810/10Vectors comprising a non-peptidic targeting moiety

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明公开了一种控制大肠杆菌中质粒复制的方法。本发明设计开发的质粒调控方法基于Crispr/Cas9系统;其利用表达的dCas9蛋白以及转录的针对于质粒复制区靶序列的gRNA,有效的实现了质粒复制的调控抑制,该方法尚未见其它文献和专利报道,是一种全新的方法。该方法中使用的针对复制区的靶序列,可以有多种选择,保证了利用不同的dCas9/gRNA对,实现不同程度的质粒复制调控的目的。该方法能够有效的降低质粒复制后产量2‑34倍,相比以前专利报道的方法,具有调控范围更广,调控能力更强的特点。总之,该方法设计新颖,能够有效实现对质粒复制不同程度的调控。

Description

一种控制大肠杆菌中质粒复制的方法
技术领域
本发明涉及生物工程领域,具体涉及一种控制大肠杆菌中质粒复制的方法。
技术背景
质粒是细胞中染色体以外,能够独立自主复制的较小的DNA分子。其长度从数千乃至几百万碱基不等。其拷贝数也能从几个到上千个不等。天然存在的质粒分子,通常对宿主细胞的生存没有决定性的作用,但是能够携带一些特殊的基因,比如抗生素抗性基因,致病调控基因等,增加宿主细胞的遗传与生理多样性。鉴于这些特点,在20世纪70年代前后,质粒DNA被开发成为有效的基因工程载体,用以携带外源基因到特定的宿主,进行基因克隆以及外源蛋白表达。
大肠杆菌(Escherichia coli)是一种革兰氏阴性短杆菌,是人和动物肠道中最主要的栖居菌之一。实验室培养的大肠杆菌通常30min能够复制一代。其基因组长度为~4.7Mb,包含大约4000个基因。由于其结构简单,培养方式简单,生长迅速,遗传背景清晰,目前已经作为模式微生物,被广泛的应用于基因工程,分子生物学,代谢工程以及合成生物学相关的研究以及工业应用中。
目前,实验室和工业应用构建的~90%以上的质粒是在大肠杆菌中进行克隆复制或者生产的。这其中包括用于表达抗原分子的DNA疫苗;用于微生物,植物,动物蛋白表达和功能研究的质粒;用于微生物,植物,动物基因编辑以及转录控制的质粒以及用于自然界生物基因库保存的质粒等。质粒在大肠杆菌中的复制状态以及拷贝数等对于利用质粒进行功能研究以及工业应用具有重要的意义。比如,通过控制质粒的复制,调控质粒上基因的表达,对于研究质粒上单基因或多基因的表达,利用质粒进行合成生物学和分子生物学的研究具有重要价值。同时,控制质粒的复制能够有效的解决毒性基因克隆或表达困难的问题。一些DNA序列,其在大肠杆菌中随机或者定向转录出来的mRNA或者翻译出来的蛋白质能够对大肠杆菌的生长造成很大的干扰。这类基因被称为毒性基因。这些毒性基因在克隆进一些特定的载体比如哺乳动物表达载体pCDNA3.1以及大肠杆菌克隆载体pUC57的时候,由于这些载体的拷贝数比较高,使得这些外源基因的mRNA转录物以及蛋白表达产物对大肠杆菌生长干扰极大的增强,造成大肠杆菌死亡或者生长停滞。控制质粒的复制,使得质粒在大肠杆菌中复制的时候能够维持在一个较低的水平,是在构建毒性基因克隆表达质粒过程中常用的一种策略。
目前,基因工程和工业应用的,绝大多数构建的质粒为ColEI类型的质粒;代表性的ColE1质粒,比如pUC,pET,p15A以及pMB1系列质粒。ColEI类型的质粒的复制依赖于复制区转录的两个小RNA,RNAI以及RNAII。RNAII全长555bp。在质粒复制开始的时候,它首先被宿主的RNA聚合酶从其启动子区转录出来,并与质粒DNA模板形成复合物。接下来,其被宿主体内的RNAase H切割,产生游离的3’羟基端,并作为引物被DNA聚合酶I识别,引导质粒的复制。RNAI全长108bp,在ColEI的复制中起着负调控的作用。它从复制起点上游的455bp处(RNAII的中间),以RNAII相反的方向转录,一直延伸到RNAII的5’转录起始区。它通过与RNAII的结合,阻止RNAII和DNA复制起始复合物的形成来抑制质粒的复制。RNAII对复制起始的正向作用和RNAI对复制起始的负向作用的平衡决定了质粒复制的拷贝数(Solar etal.1998Microbiol Mol Biol Rev;Tomizawa J.1984Cell;Camps M.2010,Recent Pat DNAGeneSeq)。
专利US 7,794,971 B1在大肠杆菌中利用诱导型的启动子表达了一个聚合酶基因pcnb的突变体,通过影响RNAI的多腺苷酸化,从而影响质粒的复制。PCNB聚合酶能够决定RNAI的多腺苷酸化,从而影响RNAI的降解以及与RNAII的复合物形成。pcnb突变体,能够大量积累RNAI的半衰产物。这些产物与RNAII的结合,从而抑制质粒的复制。该专利所述的菌株,同时被Epicentre公司(USA)开发成了商业化的感受态,对外售卖。据报道,在不诱导的情况下,其能针对性的降低CorE1类型的质粒,比如pET28a,pUC57等拷贝数4~20倍。同时,专利US 20110269184 A1利用一个诱导型的启动子在基因组上转录RNAI或RNAII,来实现CorE1类型质粒复制调控的目的。据其专利所述,其能够将pUC19质粒在细胞中的量降低10%,能够将去除RNAI序列的pUC19在细胞中的产量降低3倍左右。
然而由于专利限制以及实际使用效果一般的原因,这两种方法都无法被很好的应用。另外,由于这两种方法都是通过调控ColEI复制子起始复制的小RNA的功能,来达到调控质粒复制的目的,调控模式单一,这些方法很难用于对质粒复制的动态调控或者不同能力的调控。鉴于质粒复制调控对于调控质粒基因表达,研究质粒基因功能以及进行毒性基因克隆上的用途,开发出更加有效的,能够进行动态调控的质粒复制调控系统显得尤为必要。
发明内容
本发明的目的是提供一种调控大肠杆菌中质粒复制的方法
本发明的目的可以通过以下技术方案实现:
一种控制大肠杆菌中质粒复制的方法,包括如下步骤:
步骤1:在被调控质粒R的复制起始区,选择一段20bp的靶序列N20,其中靶序列的3’端相邻的序列为NGG;
步骤2:在大肠杆菌细胞内表达一个Cas9蛋白的失活突变体dCas9蛋白(Cas9蛋白的H840-A及D10-A双突变体)以及转录出针对被调控质粒R复制起始区靶序列N20的gRNA。
进一步的其中步骤1中靶序列的选择在质粒R复制区的正链或负链上,该靶序列具有与大肠杆菌基因组上的序列不同源的特点。
进一步的其中步骤2中gRNA的基因序列为:N20(步骤1涉及的靶序列)+GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTT(gRNA scaffold+termination sequence)。
进一步的其中步骤2中dCas9蛋白可以通过插入染色体上的dCas9基因来表达或通过带有不同于待调控的R质粒复制子的质粒来表达。
进一步的其中步骤2中dCas9蛋白为Cas9蛋白的第10位天冬氨酸以及第840位的组氨酸突变为丙氨酸的突变体(dCas9序列参考文献Jinek et al.2012,Science.所述;序列见SEQ ID NO:1;突变位点以下划线标注)。所述的dCas9蛋白可以通过插入染色体上的dCas9基因来表达或通过带有不同于待调控的R质粒复制子的质粒来表达。
进一步的其中步骤2中gRNA的表达可以通过插入染色体上的gRNA的靶基因来转录或通过带有不同于待调控的R质粒复制子的质粒来转录。
进一步的其中步骤1,2中,为了能够实现对质粒复制能力的不同程度的调控,可以选择多个针对复制起始区不同的靶序列位点设计多个gRNA表达序列。利用表达出的dCas9蛋白和转录出的不同的gRNA实现对质粒复制不同程度的调控。
本发明的有益效果:
本发明利用Crispr/Cas9系统开发出一套调控质粒复制的方法。Crispr/Cas9系统最早发现于微生物细胞中,是细菌和古细菌在进化过程中形成的一种适应性免疫防御机制,可用来对抗入侵的病毒及外源DNA。最近一些年,科学家们利用该系统的DNA编辑能力,开发出了一系列针对哺乳动物,植物,微生物的基因组编辑(基因敲除/基因敲入),基因表达调控以及染色体复制调控的工具。然而,利用Crispr/Cas9系统进行质粒复制调控尚未见报道。本发明利用表达的dCas9蛋白以及转录的针对于质粒复制区靶序列的gRNA,有效的实现了质粒复制的调控抑制,是一种全新的方法。该方法中使用的针对复制区的靶序列,可以有多种选择,保证了利用不同的dCas9/gRNA对,实现不同程度的质粒复制调控的目的(如图1为利用Crispr/Cas9系统调控质粒复制原理示意图)。本发明提供的方法比专利US 7,794,971 B1及US 20110269184 A1涉及的系统,其能够更加灵活的实现对质粒复制不同程度的调控。其能够有效的降低同等条件下复制的质粒产量2-34倍,这比已存在的专利US 7,794,971 B1及US 20110269184 A1涉及的系统调控范围更广,调控能力更强。总之,该方法具有设计新颖,适用性广的特点,能够有效实现质粒复制不同程度的调控。
附图说明:
图1利用Crispr/Cas9系统调控质粒复制原理示意图。
其中,A,染色体上或者拥有不同于R质粒复制子类型的质粒上的dCas9表达以及gRNA转录;B,dCas9和gRNA形成复合物共同调控质粒R的复制。
图2针对质粒R复制子ColEI随机选择的3个靶序列G-01,G-02,G-03序列及位置图谱。
图3表达dCas9和gRNA的pTD-1/2/3质粒图谱。
具体实施方式
实施例1:利用Crispr/Cas9系统调控携带ColE1类型复制子高拷贝质粒的复制
本实施例的目的是构建一套Crispr/Cas9系统调控携带ColEI类型复制子高拷贝质粒的复制。其步骤如下:
1.针对于ColEI类型复制子区,设计3条不同的gRNA靶序列,命名为G-01(accagcggtggtttgtttgc),G-02(tcgccactggcagcagccac),G-03(ctttctcccttcgggaagcg)(见附图2),其中靶序列的3’端相邻的序列为NGG。其中G-01位于复制区DNA的正链上,G-02,G-03位于复制区DNA的负链上。
2.针对于ColEI类型复制子高拷贝质粒,设计一个表达Crispr/Cas9调控系统的质粒,其带有如下特点:a.1个pSC101类型的温敏型复制子,保证该质粒在大肠杆菌中的复制;b.1个dCas9蛋白的表达框,保证dCas9的表达;c.1个gRNA转录框,其中编码gRNA的基因是在Lac启动子的控制下转录;Lac启动子的活力受质粒上的LacI蛋白负调控;d.1个卡拉霉素抗性基因表达框(表达卡拉霉素抗性基因)。在GenScript公司合成携带编码gRNA-1(G-01+GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTT);gRNA-2(G-02+GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTT);gRNA-3(G-03+GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTT)编码基因的质粒pTD-1,pTD-2和pTD-3(质粒图谱示意图见附图2;质粒序列见SEQ ID NO:2,其中G-01,G-02和G-03的序列以NNNNNNNNNNNNNNNNNNNN表示)。
3.测试质粒表达的Crispr/Cas9系统对ColEI类型质粒的调控。
a.取ColEI类型质粒pUC57和3个dCas9和gRNA表达质粒,pTD-1,pTD-2和pTD-3;以pUC57/pTD-1,pUC57/pTD-2和pUC57/pTD-3的双质粒组合转化大肠杆菌Top10菌株(NEB,UK),分别涂布于卡拉霉素和氨苄青霉素双抗平板,过夜培养。同时将pUC57单独转化到大肠杆菌Top10菌株(NEB,UK)中,涂布于氨苄青霉素的抗性平白上,过夜培养,作为实验对照。
b.从各平板上挑取单菌落,接种于LB液体培养基中,过夜培养。
c.按照1/500的接种量,转接到LB液体培养基中。
d.当菌株生长至OD600~1,取12ml培养物中,分3份,利用Axygen(USA)质粒小抽试剂盒抽提质粒。
e.取等量抽提的质粒用KpnI酶切,采用10ul的反应体系,37℃反应1h(选择KpnI的原因是它在pUC57,pTD-1,pTD-2和pTD-3质粒上均为单酶切位点)。利用Agilent2100Bioanalyzer检测仪(USA),检测pUC57的产量,并换算出12ml菌液抽提的pUC57的总量。
4.如下表1结果,转化有pTD-1,pTD-2,pTD-3的菌株,其pUC57的产量分别降低了1.95倍,33.7倍和18.6倍。这表明选用不同的gRNA能够不同程度的降低pUC57质粒的拷贝数,证实了我们设计的Crispr/Cas9系统能够有效的实现对质粒复制不同程度的调控。相比目前已存在的专利US 7,794,971 B1及US 20110269184 A1涉及的系统,其能够更加灵活的实现对pUC57质粒复制不同程度的调控。同时,pTD-2显示能够使得pUC57产量降低最多33.7倍,这比已存在的系统所揭示的能实现的最大程度(20倍)的调控要强得多。
表1携带pTD-1,pTD-2,pTD-3质粒的菌株中抽提的pUC57总量差异
*降低的倍数=Top10菌株中pUC57的产量/携带pTD-1,pTD-2,pTD-3质粒Top10菌株中pUC57的产量。
SEQUENCE LISTING
<110> 南京金斯瑞生物科技有限公司
<120> 一种控制大肠杆菌中质粒复制的方法
<130> 2017
<160> 2
<170> PatentIn version 3.3
<210> 1
<211> 4107
<212> DNA
<213> 人工序列
<221> dCas9蛋白编码基因
<400> 1
atggataaga aatactcaat aggcttagct atcggcacaa atagcgtcgg atgggcggtg 60
atcactgatg aatataaggt tccgtctaaa aagttcaagg ttctgggaaa tacagaccgc 120
cacagtatca aaaaaaatct tataggggct cttttatttg acagtggaga gacagcggaa 180
gcgactcgtc tcaaacggac agctcgtaga aggtatacac gtcggaagaa tcgtatttgt 240
tatctacagg agattttttc aaatgagatg gcgaaagtag atgatagttt ctttcatcga 300
cttgaagagt cttttttggt ggaagaagac aagaagcatg aacgtcatcc tatttttgga 360
aatatagtag atgaagttgc ttatcatgag aaatatccaa ctatctatca tctgcgaaaa 420
aaattggtag attctactga taaagcggat ttgcgcttaa tctatttggc cttagcgcat 480
atgattaagt ttcgtggtca ttttttgatt gagggagatt taaatcctga taatagtgat 540
gtggacaaac tatttatcca gttggtacaa acctacaatc aattatttga agaaaaccct 600
attaacgcaa gtggagtaga tgctaaagcg attctttctg cacgattgag taaatcaaga 660
cgattagaaa atctcattgc tcagctcccc ggtgagaaga aaaatggctt atttgggaat 720
ctcattgctt tgtcattggg tttgacccct aattttaaat caaattttga tttggcagaa 780
gatgctaaat tacagctttc aaaagatact tacgatgatg atttagataa tttattggcg 840
caaattggag atcaatatgc tgatttgttt ttggcagcta agaatttatc agatgctatt 900
ttactttcag atatcctaag agtaaatact gaaataacta aggctcccct atcagcttca 960
atgattaaac gctacgatga acatcatcaa gacttgactc ttttaaaagc tttagttcga 1020
caacaacttc cagaaaagta taaagaaatc ttttttgatc aatcaaaaaa cggatatgca 1080
ggttatattg atgggggagc tagccaagaa gaattttata aatttatcaa accaatttta 1140
gaaaaaatgg atggtactga ggaattattg gtgaaactaa atcgtgaaga tttgctgcgc 1200
aagcaacgga cctttgacaa cggctctatt ccccatcaaa ttcacttggg tgagctgcat 1260
gctattttga gaagacaaga agacttttat ccatttttaa aagacaatcg tgagaagatt 1320
gaaaaaatct tgacttttcg aattccttat tatgttggtc cattggcgcg tggcaatagt 1380
cgttttgcat ggatgactcg gaagtctgaa gaaacaatta ccccatggaa ttttgaagaa 1440
gttgtcgata aaggtgcttc agctcaatca tttattgaac gcatgacaaa ctttgataaa 1500
aatcttccaa atgaaaaagt actaccaaaa catagtttgc tttatgagta ttttacggtt 1560
tataacgaat tgacaaaggt caaatatgtt actgaaggaa tgcgaaaacc agcatttctt 1620
tcaggtgaac agaagaaagc cattgttgat ttactcttca aaacaaatcg aaaagtaacc 1680
gttaagcaat taaaagaaga ttatttcaaa aaaatagaat gttttgatag tgttgaaatt 1740
tcaggagttg aagatagatt taatgcttca ttaggtacct accatgattt gctaaaaatt 1800
attaaagata aagatttttt ggataatgaa gaaaatgaag atatcttaga ggatattgtt 1860
ttaacattga ccttatttga agatagggag atgattgagg aaagacttaa aacatatgct 1920
cacctctttg atgataaggt gatgaaacag cttaaacgtc gccgttatac tggttgggga 1980
cgtttgtctc gaaaattgat taatggtatt agggataagc aatctggcaa aacaatatta 2040
gattttttga aatcagatgg ttttgccaat cgcaatttta tgcagctgat ccatgatgat 2100
agtttgacat ttaaagaaga cattcaaaaa gcacaagtgt ctggacaagg cgatagttta 2160
catgaacata ttgcaaattt agctggtagc cctgctatta aaaaaggtat tttacagact 2220
gtaaaagttg ttgatgaatt ggtcaaagta atggggcggc ataagccaga aaatatcgtt 2280
attgaaatgg cacgtgaaaa tcagacaact caaaagggcc agaaaaattc gcgagagcgt 2340
atgaaacgaa tcgaagaagg tatcaaagaa ttaggaagtc agattcttaa agagcatcct 2400
gttgaaaata ctcaattgca aaatgaaaag ctctatctct attatctcca aaatggaaga 2460
gacatgtatg tggaccaaga attagatatt aatcgtttaa gtgattatga tgtcgatgcc 2520
attgttccac aaagtttcct taaagacgat tcaatagaca ataaggtctt aacgcgttct 2580
gataaaaatc gtggtaaatc ggataacgtt ccaagtgaag aagtagtcaa aaagatgaaa 2640
aactattgga gacaacttct aaacgccaag ttaatcactc aacgtaagtt tgataattta 2700
acgaaagctg aacgtggagg tttgagtgaa cttgataaag ctggttttat caaacgccaa 2760
ttggttgaaa ctcgccaaat cactaagcat gtggcacaaa ttttggatag tcgcatgaat 2820
actaaatacg atgaaaatga taaacttatt cgagaggtta aagtgattac cttaaaatct 2880
aaattagttt ctgacttccg aaaagatttc caattctata aagtacgtga gattaacaat 2940
taccatcatg cccatgatgc gtatctaaat gccgtcgttg gaactgcttt gattaagaaa 3000
tatccaaaac ttgaatcgga gtttgtctat ggtgattata aagtttatga tgttcgtaaa 3060
atgattgcta agtctgagca agaaataggc aaagcaaccg caaaatattt cttttactct 3120
aatatcatga acttcttcaa aacagaaatt acacttgcaa atggagagat tcgcaaacgc 3180
cctctaatcg aaactaatgg ggaaactgga gaaattgtct gggataaagg gcgagatttt 3240
gccacagtgc gcaaagtatt gtccatgccc caagtcaata ttgtcaagaa aacagaagta 3300
cagacaggcg gattctccaa ggagtcaatt ttaccaaaaa gaaattcgga caagcttatt 3360
gctcgtaaaa aagactggga tccaaaaaaa tatggtggtt ttgatagtcc aacggtagct 3420
tattcagtcc tagtggttgc taaggtggaa aaagggaaat cgaagaagtt aaaatccgtt 3480
aaagagttac tagggatcac aattatggaa agaagttcct ttgaaaaaaa tccgattgac 3540
tttttagaag ctaaaggata taaggaagtt aaaaaagact taatcattaa actacctaaa 3600
tatagtcttt ttgagttaga aaacggtcgt aaacggatgc tggctagtgc cggagaatta 3660
caaaaaggaa atgagctggc tctgccaagc aaatatgtga attttttata tttagctagt 3720
cattatgaaa agttgaaggg tagtccagaa gataacgaac aaaaacaatt gtttgtggag 3780
cagcataagc attatttaga tgagattatt gagcaaatca gtgaattttc taagcgtgtt 3840
attttagcag atgccaattt agataaagtt cttagtgcat ataacaaaca tagagacaaa 3900
ccaatacgtg aacaagcaga aaatattatt catttattta cgttgacgaa tcttggagct 3960
cccgctgctt ttaaatattt tgatacaaca attgatcgta aacgatatac gtctacaaaa 4020
gaagttttag atgccactct tatccatcaa tccatcactg gtctttatga aacacgcatt 4080
gatttgagtc agctaggagg tgactaa 4107
<210> 2
<211> 9426
<212> DNA
<213> 人工序列
<220>
<221> misc_feature
<222> (90)..(109)
<223> n is a, c, g, or t
<400> 2
gatctcaaaa aaagcaccga ctcggtgcca ctttttcaag ttgataacgg actagcctta 60
ttttaacttg ctatttctag ctctaaaacn nnnnnnnnnn nnnnnnnnnt gtgtgaaatt 120
gttatccgct cacaattcca cacattatac gagccggatg attaattgtc aacagctcat 180
ttcagaatat ttgccagaac cgttatgatg tcggcgcaaa aaacattatc cagaacggga 240
gtgcgccttg agcgacacga attatgcagt gatttacgac ctgcacagcc ataccacagc 300
ttccgatggc tgcctgacgc cagaagcatt ggtgcaccgt gcagtcgatg ataagctgtc 360
aaaccagatc aattcgcgct aactcacatt aattgcgttg cgctcactgc ccgctttcca 420
gtcgggaaac ctgtcgtgcc agctgcatta atgaatcggc caacgcgcgg ggagaggcgg 480
tttgcgtatt gggcgccagg gtggtttttc ttttcaccag tgagacgggc aacagctgat 540
tgcccttcac cgcctggccc tgagagagtt gcagcaagcg gtccacgctg gtttgcccca 600
gcaggcgaaa atcctgtttg atggtggttg acggcgggat ataacatgag ctgtcttcgg 660
tatcgtcgta tcccactacc gagatatccg caccaacgcg cagcccggac tcggtaatgg 720
cgcgcattgc gcccagcgcc atctgatcgt tggcaaccag catcgcagtg ggaacgatgc 780
cctcattcag catttgcatg gtttgttgaa aaccggacat ggcactccag tcgccttccc 840
gttccgctat cggctgaatt tgattgcgag tgagatattt atgccagcca gccagacgca 900
gacgcgccga gacagaactt aatgggcccg ctaacagcgc gatttgctgg tgacccaatg 960
cgaccagatg ctccacgccc agtcgcgtac cgtcttcatg ggagaaaata atactgttga 1020
tgggtgtctg gtcagagaca tcaagaaata acgccggaac attagtgcag gcagcttcca 1080
cagcaatggc atcctggtca tccagcggat agttaatgat cagcccactg acgcgttgcg 1140
cgagaagatt gtgcaccgcc gctttacagg cttcgacgcc gcttcgttct accatcgaca 1200
ccaccacgct ggcacccagt tgatcggcgc gagatttaat cgccgcgaca atttgcgacg 1260
gcgcgtgcag ggccagactg gaggtggcaa cgccaatcag caacgactgt ttgcccgcca 1320
gttgttgtgc cacgcggttg ggaatgtaat tcagctccgc catcgccgct tccacttttt 1380
cccgcgtttt cgcagaaacg tggctggcct ggttcaccac gcgggaaacg gtctgataag 1440
agacaccggc atactctgcg acatcgtata acgttactgg tttcacattc accaccctga 1500
attgactctc ttccgggcgc tatcatgcca taccgcgaaa ggttttgcac cattcgatgg 1560
tgtcaacgta aatgcatgcc gcttcgcctt ccatgggtat ggacagtttt ccctttgata 1620
tgtaacggtg aacagttgtt ctacttttgt ttgttagtct tgatgcttca ctgatagata 1680
caagagccat aagaacctca gatccttccg tatttagcca gtatgttctc tagtgtggtt 1740
cgttgttttt gcgtgagcca tgagaacgaa ccattgagat catacttact ttgcatgtca 1800
ctcaaaaatt ttgcctcaaa actggtgagc tgaatttttg cagttaaagc atcgtgtagt 1860
gtttttctta gtccgttacg taggtaggaa tctgatgtaa tggttgttgg tattttgtca 1920
ccattcattt ttatctggtt gttctcaagt tcggttacga gatccatttg tctatctagt 1980
tcaacttgga aaatcaacgt atcagtcggg cggcctcgct tatcaaccac caatttcata 2040
ttgctgtaag tgtttaaatc tttacttatt ggtttcaaaa cccattggtt aagcctttta 2100
aactcatggt agttattttc aagcattaac atgaacttaa attcatcaag gctaatctct 2160
atatttgcct tgtgagtttt cttttgtgtt agttctttta ataaccactc ataaatcctc 2220
atagagtatt tgttttcaaa agacttaaca tgttccagat tatattttat gaattttttt 2280
aactggaaaa gataaggcaa tatctcttca ctaaaaacta attctaattt ttcgcttgag 2340
aacttggcat agtttgtcca ctggaaaatc tcaaagcctt taaccaaagg attcctgatt 2400
tccacagttc tcgtcatcag ctctctggtt gctttagcta atacaccata agcattttcc 2460
ctactgatgt tcatcatctg agcgtattgg ttataagtga acgataccgt ccgttctttc 2520
cttgtagggt tttcaatcgt ggggttgagt agtgccacac agcataaaat tagcttggtt 2580
tcatgctccg ttaagtcata gcgactaatc gctagttcat ttgctttgaa aacaactaat 2640
tcagacatac atctcaattg gtctaggtga ttttaatcac tataccaatt gagatgggct 2700
agtcaatgat aattactagt ccttttcctt tgagttgtgg gtatctgtaa attctgctag 2760
acctttgctg gaaaacttgt aaattctgct agaccctctg taaattccgc tagacctttg 2820
tgtgtttttt ttgtttatat tcaagtggtt ataatttata gaataaagaa agaataaaaa 2880
aagataaaaa gaatagatcc cagccctgtg tataactcac tactttagtc agttccgcag 2940
tattacaaaa ggatgtcgca aacgctgttt gctcctctac aaaacagacc ttaaaaccct 3000
aaaggcttaa gtagcaccct cgcaagctcg gttgcggccg caatcgggca aatcgctgaa 3060
tattcctttt gtctccgacc atcaggcacc tgagtcgctg tctttttcgt gacattcagt 3120
tcgctgcgct cacggctctg gcagtgaatg ggggtaaatg gcactacagg cgccttttat 3180
ggattcatgc aaggaaacta cccataatac aagaaaagcc cgtcacgggc ttctcagggc 3240
gttttatggc gggtctgcta tgtggtgcta tctgactttt tgctgttcag cagttcctgc 3300
cctctgattt tccagtctga ccacttcgga ttatcccgtg acaggtcatt cagactggct 3360
aatgcaccca gtaaggcagc ggtatcatca acggggtctg acgctcagtg gaacgaaaac 3420
tcacgttaag ggattttggt catgagatta tcaaaaagga tcttcaccta gatcctttta 3480
aattaaaaat gaagttttaa atcaatctaa agtatatatg agtaaacttg gtctgacagt 3540
tacgtttcca caaccaatta accaattctg attagaaaaa ctcatcgagc atcaaatgaa 3600
actgcaattt attcatatca ggattatcaa taccatattt ttgaaaaagc cgtttctgta 3660
atgaaggaga aaactcaccg aggcagttcc ataggatggc aagatcctgg tatcggtctg 3720
cgattccgac tcgtccaaca tcaatacaac ctattaattt cccctcgtca aaaataaggt 3780
tatcaagtga gaaatcacca tgagtgacga ctgaatccgg tgagaatggc aaaagcttat 3840
gcatttcttt ccagacttgt tcaacaggcc agccattacg ctcgtcatca aaatcactcg 3900
catcaaccaa accgttattc attcgtgatt gcgcctgagc gagacgaaat acgcgatcgc 3960
tgttaaaagg acaattacaa acaggaatcg aatgcaaccg gcgcaggaac actgccagcg 4020
catcaacaat attttcacct gaatcaggat attcttctaa tacctggaat gctgttttcc 4080
cggggatcgc agtggtgagt aaccatgcat catcaggagt acggataaaa tgcttgatgg 4140
tcggaagagg cataaattcc gtcagccagt ttagtctgac catctcatct gtaacatcat 4200
tggcaacgct acctttgcca tgtttcagaa acaactctgg cgcatcgggc ttcccataca 4260
atcgatagat tgtcgcacct gattgcccga cattatcgcg agcccattta tacccatata 4320
aatcagcatc catgttggaa tttaatcgcg gcctcgagca agacgtttcc cgttgaatat 4380
ggctcataac accccttgta ttactgttta tgtaagcaga cagttttatt gttcatgatg 4440
atatattttt atcttgtgca atgtaacatc agagattttg agacacaacg tggctttccc 4500
tgcagggttt gcagtcagag tagaatagaa gtatcaaaaa aagcaccgac tcggtgccac 4560
tttttcaagt tgataacgga ctagccttat tttaacttgc tatgctgttt tgaatggttc 4620
caacaagatt attttataac ttttataaca aataatcaag gagaaattca aagaaattta 4680
tcagccataa aacaatactt aatactatag aatgataaca aaataaacta ctttttaaaa 4740
gaattttgtg ttataatcta tttattatta agtattgggt aatatttttt gaagagatat 4800
tttgaaaaag aaaaattaaa gcatattaaa ctaatttcgg aggtcattaa aactattatt 4860
gaaatcatca aactcattat ggatttaatt taaacttttt attttaggag gcaaaaatgg 4920
ataagaaata ctcaataggc ttagctatcg gcacaaatag cgtcggatgg gcggtgatca 4980
ctgatgaata taaggttccg tctaaaaagt tcaaggttct gggaaataca gaccgccaca 5040
gtatcaaaaa aaatcttata ggggctcttt tatttgacag tggagagaca gcggaagcga 5100
ctcgtctcaa acggacagct cgtagaaggt atacacgtcg gaagaatcgt atttgttatc 5160
tacaggagat tttttcaaat gagatggcga aagtagatga tagtttcttt catcgacttg 5220
aagagtcttt tttggtggaa gaagacaaga agcatgaacg tcatcctatt tttggaaata 5280
tagtagatga agttgcttat catgagaaat atccaactat ctatcatctg cgaaaaaaat 5340
tggtagattc tactgataaa gcggatttgc gcttaatcta tttggcctta gcgcatatga 5400
ttaagtttcg tggtcatttt ttgattgagg gagatttaaa tcctgataat agtgatgtgg 5460
acaaactatt tatccagttg gtacaaacct acaatcaatt atttgaagaa aaccctatta 5520
acgcaagtgg agtagatgct aaagcgattc tttctgcacg attgagtaaa tcaagacgat 5580
tagaaaatct cattgctcag ctccccggtg agaagaaaaa tggcttattt gggaatctca 5640
ttgctttgtc attgggtttg acccctaatt ttaaatcaaa ttttgatttg gcagaagatg 5700
ctaaattaca gctttcaaaa gatacttacg atgatgattt agataattta ttggcgcaaa 5760
ttggagatca atatgctgat ttgtttttgg cagctaagaa tttatcagat gctattttac 5820
tttcagatat cctaagagta aatactgaaa taactaaggc tcccctatca gcttcaatga 5880
ttaaacgcta cgatgaacat catcaagact tgactctttt aaaagcttta gttcgacaac 5940
aacttccaga aaagtataaa gaaatctttt ttgatcaatc aaaaaacgga tatgcaggtt 6000
atattgatgg gggagctagc caagaagaat tttataaatt tatcaaacca attttagaaa 6060
aaatggatgg tactgaggaa ttattggtga aactaaatcg tgaagatttg ctgcgcaagc 6120
aacggacctt tgacaacggc tctattcccc atcaaattca cttgggtgag ctgcatgcta 6180
ttttgagaag acaagaagac ttttatccat ttttaaaaga caatcgtgag aagattgaaa 6240
aaatcttgac ttttcgaatt ccttattatg ttggtccatt ggcgcgtggc aatagtcgtt 6300
ttgcatggat gactcggaag tctgaagaaa caattacccc atggaatttt gaagaagttg 6360
tcgataaagg tgcttcagct caatcattta ttgaacgcat gacaaacttt gataaaaatc 6420
ttccaaatga aaaagtacta ccaaaacata gtttgcttta tgagtatttt acggtttata 6480
acgaattgac aaaggtcaaa tatgttactg aaggaatgcg aaaaccagca tttctttcag 6540
gtgaacagaa gaaagccatt gttgatttac tcttcaaaac aaatcgaaaa gtaaccgtta 6600
agcaattaaa agaagattat ttcaaaaaaa tagaatgttt tgatagtgtt gaaatttcag 6660
gagttgaaga tagatttaat gcttcattag gtacctacca tgatttgcta aaaattatta 6720
aagataaaga ttttttggat aatgaagaaa atgaagatat cttagaggat attgttttaa 6780
cattgacctt atttgaagat agggagatga ttgaggaaag acttaaaaca tatgctcacc 6840
tctttgatga taaggtgatg aaacagctta aacgtcgccg ttatactggt tggggacgtt 6900
tgtctcgaaa attgattaat ggtattaggg ataagcaatc tggcaaaaca atattagatt 6960
ttttgaaatc agatggtttt gccaatcgca attttatgca gctgatccat gatgatagtt 7020
tgacatttaa agaagacatt caaaaagcac aagtgtctgg acaaggcgat agtttacatg 7080
aacatattgc aaatttagct ggtagccctg ctattaaaaa aggtatttta cagactgtaa 7140
aagttgttga tgaattggtc aaagtaatgg ggcggcataa gccagaaaat atcgttattg 7200
aaatggcacg tgaaaatcag acaactcaaa agggccagaa aaattcgcga gagcgtatga 7260
aacgaatcga agaaggtatc aaagaattag gaagtcagat tcttaaagag catcctgttg 7320
aaaatactca attgcaaaat gaaaagctct atctctatta tctccaaaat ggaagagaca 7380
tgtatgtgga ccaagaatta gatattaatc gtttaagtga ttatgatgtc gatgccattg 7440
ttccacaaag tttccttaaa gacgattcaa tagacaataa ggtcttaacg cgttctgata 7500
aaaatcgtgg taaatcggat aacgttccaa gtgaagaagt agtcaaaaag atgaaaaact 7560
attggagaca acttctaaac gccaagttaa tcactcaacg taagtttgat aatttaacga 7620
aagctgaacg tggaggtttg agtgaacttg ataaagctgg ttttatcaaa cgccaattgg 7680
ttgaaactcg ccaaatcact aagcatgtgg cacaaatttt ggatagtcgc atgaatacta 7740
aatacgatga aaatgataaa cttattcgag aggttaaagt gattacctta aaatctaaat 7800
tagtttctga cttccgaaaa gatttccaat tctataaagt acgtgagatt aacaattacc 7860
atcatgccca tgatgcgtat ctaaatgccg tcgttggaac tgctttgatt aagaaatatc 7920
caaaacttga atcggagttt gtctatggtg attataaagt ttatgatgtt cgtaaaatga 7980
ttgctaagtc tgagcaagaa ataggcaaag caaccgcaaa atatttcttt tactctaata 8040
tcatgaactt cttcaaaaca gaaattacac ttgcaaatgg agagattcgc aaacgccctc 8100
taatcgaaac taatggggaa actggagaaa ttgtctggga taaagggcga gattttgcca 8160
cagtgcgcaa agtattgtcc atgccccaag tcaatattgt caagaaaaca gaagtacaga 8220
caggcggatt ctccaaggag tcaattttac caaaaagaaa ttcggacaag cttattgctc 8280
gtaaaaaaga ctgggatcca aaaaaatatg gtggttttga tagtccaacg gtagcttatt 8340
cagtcctagt ggttgctaag gtggaaaaag ggaaatcgaa gaagttaaaa tccgttaaag 8400
agttactagg gatcacaatt atggaaagaa gttcctttga aaaaaatccg attgactttt 8460
tagaagctaa aggatataag gaagttaaaa aagacttaat cattaaacta cctaaatata 8520
gtctttttga gttagaaaac ggtcgtaaac ggatgctggc tagtgccgga gaattacaaa 8580
aaggaaatga gctggctctg ccaagcaaat atgtgaattt tttatattta gctagtcatt 8640
atgaaaagtt gaagggtagt ccagaagata acgaacaaaa acaattgttt gtggagcagc 8700
ataagcatta tttagatgag attattgagc aaatcagtga attttctaag cgtgttattt 8760
tagcagatgc caatttagat aaagttctta gtgcatataa caaacataga gacaaaccaa 8820
tacgtgaaca agcagaaaat attattcatt tatttacgtt gacgaatctt ggagctcccg 8880
ctgcttttaa atattttgat acaacaattg atcgtaaacg atatacgtct acaaaagaag 8940
ttttagatgc cactcttatc catcaatcca tcactggtct ttatgaaaca cgcattgatt 9000
tgagtcagct aggaggtgac taaagtatat tttagatgaa gattatttct taatctagac 9060
atgagcggat acatatttga atgtatttag aaaaataaac aaataggggt tccgcgcaca 9120
tttccccgaa aagtgccacc tgcatcgatt tcgcatcctc acgataatat ccgggtaggc 9180
gcaatcactt tcgtctactc cgttacaaag cgaggctggg tatttcccgg cctttctgtt 9240
atccgaaatc cactgaaagc acagcggctg gctgaggaga taaataataa acgaggggct 9300
gtatgcacaa agcatcttct gttgagttaa gaacgagtat cgagatggca catagccttg 9360
ctcaaattgg aatcaggttt gtgccaatac cagtagaaac agacgaagaa tccatgggta 9420
tggaca 9426

Claims (7)

1.一种控制大肠杆菌中质粒复制的方法,其特征在于:包括如下步骤:
步骤1:在被调控质粒R的复制起始区,选择一段20bp的靶序列N20,其中靶序列的3’端相邻的序列为NGG;
步骤2:在大肠杆菌细胞内表达一个Cas9蛋白的失活突变体dCas9蛋白以及转录出针对被调控质粒R复制起始区靶序列N20的gRNA。
2.根据权利要求1所述的方法,其特征在于:步骤1中靶序列的选择在质粒R复制区的正链或负链上,该靶序列具有与大肠杆菌基因组上的序列不同源的特点。
3.根据权利要求1所述的方法,其特征在于:步骤2中gRNA的基因序列为:N20+GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTT。
4.根据权利要求1所述的方法,其特征在于:步骤2中dCas9蛋白可以通过插入染色体上的dCas9基因来表达或通过带有不同于待调控的R质粒复制子的质粒来表达。
5.根据权利要求1所述的方法,其特征在于:步骤2中gRNA的表达可以通过插入染色体上的gRNA的靶基因来转录或通过带有不同于待调控的R质粒复制子的质粒来转录。
6.根据权利要求1所述的方法,其特征在于:选择转录针对不同靶序列的gRNA来实现对质粒复制不同程度的调控。
7.根据权利要求1所述的方法,其特征在于:选择对dCas9的表达以及gRNA的转录进行调控,以实现对质粒复制不同程度的调控。
CN201710413737.XA 2017-06-05 2017-06-05 一种控制大肠杆菌中质粒复制的方法 Pending CN107142272A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710413737.XA CN107142272A (zh) 2017-06-05 2017-06-05 一种控制大肠杆菌中质粒复制的方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710413737.XA CN107142272A (zh) 2017-06-05 2017-06-05 一种控制大肠杆菌中质粒复制的方法

Publications (1)

Publication Number Publication Date
CN107142272A true CN107142272A (zh) 2017-09-08

Family

ID=59780907

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710413737.XA Pending CN107142272A (zh) 2017-06-05 2017-06-05 一种控制大肠杆菌中质粒复制的方法

Country Status (1)

Country Link
CN (1) CN107142272A (zh)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9999671B2 (en) 2013-09-06 2018-06-19 President And Fellows Of Harvard College Delivery of negatively charged proteins using cationic lipids
US10113163B2 (en) 2016-08-03 2018-10-30 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
US10167457B2 (en) 2015-10-23 2019-01-01 President And Fellows Of Harvard College Nucleobase editors and uses thereof
US10465176B2 (en) 2013-12-12 2019-11-05 President And Fellows Of Harvard College Cas variants for gene editing
US10508298B2 (en) 2013-08-09 2019-12-17 President And Fellows Of Harvard College Methods for identifying a target site of a CAS9 nuclease
US10597679B2 (en) 2013-09-06 2020-03-24 President And Fellows Of Harvard College Switchable Cas9 nucleases and uses thereof
US10704062B2 (en) 2014-07-30 2020-07-07 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
US10858639B2 (en) 2013-09-06 2020-12-08 President And Fellows Of Harvard College CAS9 variants and uses thereof
US11046948B2 (en) 2013-08-22 2021-06-29 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US11268082B2 (en) 2017-03-23 2022-03-08 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable DNA binding proteins
US11306324B2 (en) 2016-10-14 2022-04-19 President And Fellows Of Harvard College AAV delivery of nucleobase editors
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
US11447770B1 (en) 2019-03-19 2022-09-20 The Broad Institute, Inc. Methods and compositions for prime editing nucleotide sequences
US11542496B2 (en) 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
CN115851795A (zh) * 2022-07-19 2023-03-28 广州派真生物技术有限公司 一种高产质粒、其构建方法及其应用
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
US11732274B2 (en) 2017-07-28 2023-08-22 President And Fellows Of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
US11795443B2 (en) 2017-10-16 2023-10-24 The Broad Institute, Inc. Uses of adenosine base editors
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
US11912985B2 (en) 2020-05-08 2024-02-27 The Broad Institute, Inc. Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
US12006520B2 (en) 2011-07-22 2024-06-11 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7794971B1 (en) * 2003-07-01 2010-09-14 Epicentre Technologies Corporation Compositions and methods for controlling copy number for a broad range of plasmids and uses thereof
CN102443599A (zh) * 2011-11-03 2012-05-09 中国药科大学 可诱导增加拷贝数的质粒及其用于筛选正交性琥珀抑制tRNA
CN103555644A (zh) * 2004-09-17 2014-02-05 贝林格尔.英格海姆Rcv两合公司 用于无抗生素ColE1质粒增殖的宿主-载体系统
WO2016094872A1 (en) * 2014-12-12 2016-06-16 The Broad Institute Inc. Dead guides for crispr transcription factors
CA2974681A1 (fr) * 2015-01-29 2016-08-04 Meiogenix Procede pour induire des recombinaisons meiotiques ciblees
CN106755037A (zh) * 2016-12-07 2017-05-31 安徽大学 一种维吉尼亚链霉菌IBL14 type I‑B‑sv14型CAS基因编辑系统
CN110129246A (zh) * 2019-04-29 2019-08-16 华南农业大学 一株供体菌、其构建方法与应用以及质粒抑制剂筛选方法

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7794971B1 (en) * 2003-07-01 2010-09-14 Epicentre Technologies Corporation Compositions and methods for controlling copy number for a broad range of plasmids and uses thereof
CN103555644A (zh) * 2004-09-17 2014-02-05 贝林格尔.英格海姆Rcv两合公司 用于无抗生素ColE1质粒增殖的宿主-载体系统
CN102443599A (zh) * 2011-11-03 2012-05-09 中国药科大学 可诱导增加拷贝数的质粒及其用于筛选正交性琥珀抑制tRNA
WO2016094872A1 (en) * 2014-12-12 2016-06-16 The Broad Institute Inc. Dead guides for crispr transcription factors
US20170321214A1 (en) * 2014-12-12 2017-11-09 The Broad Institute Inc. Dead guides for crispr transcription factors
CA2974681A1 (fr) * 2015-01-29 2016-08-04 Meiogenix Procede pour induire des recombinaisons meiotiques ciblees
CN106755037A (zh) * 2016-12-07 2017-05-31 安徽大学 一种维吉尼亚链霉菌IBL14 type I‑B‑sv14型CAS基因编辑系统
CN110129246A (zh) * 2019-04-29 2019-08-16 华南农业大学 一株供体菌、其构建方法与应用以及质粒抑制剂筛选方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CAO QH等: "Using the CRISPR/Cas9 system to eliminate native plasmids of Zymomonas mobilis ZM4", 《BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY》 *
LEI S QI等: "Repurposing CRISPR as an RNA-guided Platform for Sequence-Specific Control of Gene Expression", 《CELL》 *
沈天翔等: "质粒复制与反义RNA的调控机制 ", 《中国生物工程杂志》 *
王成双等: "弓形虫Rop46基因敲除虫株的构建及其生长复制能力评价 ", 《中国预防兽医学报》 *
王瑶等: "在大肠杆菌中利用SCLM系统进行高效率λ-Red基因敲除/整合的新策略", 《微生物学通报》 *

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12006520B2 (en) 2011-07-22 2024-06-11 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US10954548B2 (en) 2013-08-09 2021-03-23 President And Fellows Of Harvard College Nuclease profiling system
US11920181B2 (en) 2013-08-09 2024-03-05 President And Fellows Of Harvard College Nuclease profiling system
US10508298B2 (en) 2013-08-09 2019-12-17 President And Fellows Of Harvard College Methods for identifying a target site of a CAS9 nuclease
US11046948B2 (en) 2013-08-22 2021-06-29 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9999671B2 (en) 2013-09-06 2018-06-19 President And Fellows Of Harvard College Delivery of negatively charged proteins using cationic lipids
US10597679B2 (en) 2013-09-06 2020-03-24 President And Fellows Of Harvard College Switchable Cas9 nucleases and uses thereof
US10682410B2 (en) 2013-09-06 2020-06-16 President And Fellows Of Harvard College Delivery system for functional nucleases
US11299755B2 (en) 2013-09-06 2022-04-12 President And Fellows Of Harvard College Switchable CAS9 nucleases and uses thereof
US10858639B2 (en) 2013-09-06 2020-12-08 President And Fellows Of Harvard College CAS9 variants and uses thereof
US10912833B2 (en) 2013-09-06 2021-02-09 President And Fellows Of Harvard College Delivery of negatively charged proteins using cationic lipids
US11053481B2 (en) 2013-12-12 2021-07-06 President And Fellows Of Harvard College Fusions of Cas9 domains and nucleic acid-editing domains
US10465176B2 (en) 2013-12-12 2019-11-05 President And Fellows Of Harvard College Cas variants for gene editing
US11124782B2 (en) 2013-12-12 2021-09-21 President And Fellows Of Harvard College Cas variants for gene editing
US10704062B2 (en) 2014-07-30 2020-07-07 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
US11578343B2 (en) 2014-07-30 2023-02-14 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
US12043852B2 (en) 2015-10-23 2024-07-23 President And Fellows Of Harvard College Evolved Cas9 proteins for gene editing
US10167457B2 (en) 2015-10-23 2019-01-01 President And Fellows Of Harvard College Nucleobase editors and uses thereof
US11214780B2 (en) 2015-10-23 2022-01-04 President And Fellows Of Harvard College Nucleobase editors and uses thereof
US10113163B2 (en) 2016-08-03 2018-10-30 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
US10947530B2 (en) 2016-08-03 2021-03-16 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
US11999947B2 (en) 2016-08-03 2024-06-04 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
US11702651B2 (en) 2016-08-03 2023-07-18 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
US12084663B2 (en) 2016-08-24 2024-09-10 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
US11306324B2 (en) 2016-10-14 2022-04-19 President And Fellows Of Harvard College AAV delivery of nucleobase editors
US11820969B2 (en) 2016-12-23 2023-11-21 President And Fellows Of Harvard College Editing of CCR2 receptor gene to protect against HIV infection
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
US11542496B2 (en) 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
US11268082B2 (en) 2017-03-23 2022-03-08 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable DNA binding proteins
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
US11732274B2 (en) 2017-07-28 2023-08-22 President And Fellows Of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
US11932884B2 (en) 2017-08-30 2024-03-19 President And Fellows Of Harvard College High efficiency base editors comprising Gam
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
US11795443B2 (en) 2017-10-16 2023-10-24 The Broad Institute, Inc. Uses of adenosine base editors
US11447770B1 (en) 2019-03-19 2022-09-20 The Broad Institute, Inc. Methods and compositions for prime editing nucleotide sequences
US11643652B2 (en) 2019-03-19 2023-05-09 The Broad Institute, Inc. Methods and compositions for prime editing nucleotide sequences
US11795452B2 (en) 2019-03-19 2023-10-24 The Broad Institute, Inc. Methods and compositions for prime editing nucleotide sequences
US11912985B2 (en) 2020-05-08 2024-02-27 The Broad Institute, Inc. Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
US12031126B2 (en) 2020-05-08 2024-07-09 The Broad Institute, Inc. Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
CN115851795A (zh) * 2022-07-19 2023-03-28 广州派真生物技术有限公司 一种高产质粒、其构建方法及其应用
CN115851795B (zh) * 2022-07-19 2023-09-01 广州派真生物技术有限公司 一种高产质粒、其构建方法及其应用

Similar Documents

Publication Publication Date Title
CN107142272A (zh) 一种控制大肠杆菌中质粒复制的方法
US10913941B2 (en) Enzymes with RuvC domains
KR102623312B1 (ko) Ruvc 도메인이 존재하는 효소
JP7546689B2 (ja) クラス2のii型crisprシステム
US11279940B2 (en) Iterative genome editing in microbes
CN102703424B (zh) 一种重组工程介导的大肠杆菌基因组点突变的方法
EP4146800A1 (en) Enzymes with ruvc domains
JP2021509582A (ja) ブドウ球菌(Staphylococcus)属細菌の栄養要求株
CA3234233A1 (en) Endonuclease systems
JP2022524044A (ja) 微生物のプール型ゲノム編集
US20210285014A1 (en) Pooled genome editing in microbes
US20220220460A1 (en) Enzymes with ruvc domains
CN113151133B (zh) 一种产唾液酸乳糖的重组宿主菌及其构建方法和应用
EP4423277A1 (en) Enzymes with hepn domains
US20210115500A1 (en) Genotyping edited microbial strains
CN114829602A (zh) 拟杆菌属中的基因组编辑
CN111040025B (zh) Yp_2058蛋白在调控鼠疫耶尔森菌毒力中的应用
US20240352433A1 (en) Enzymes with hepn domains
CN115976058B (zh) 毒素基因及其在重组和/或基因编辑的工程菌构建中的应用
CN118028206A (zh) 一种用于制备l-岩藻糖的工程菌及其应用
Ding et al. Rapidly engineering an osmotic-pressure-tolerant gut bacterium for efficient non-sterile production of bulk chemicals
CN115369098A (zh) 一种新型crispr相关转座酶
GB2594339A (en) Enzymes with RUVC Domains
CN118256520A (zh) 一种红法夫酵母的自主复制序列及其应用
CN103130879A (zh) 跨膜转运蛋白及其编码基因和它们的应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170908